Resources
Transforming WHO Recommendations into Practice
This technical brief discusses how the West African countries within the Act | West portfolio have transformed WHO guidelines and recommendations into practical approaches to achieve interruption of onchocerciasis transmission.
Act | West FY 23 Semi-Annual Report: April 2023 - September 2023
This report outlines the key achievements and challenges in the last six months of the fifth year of program implementation, spanning the period April 2023 - September 2023.
Partnering with Countries to Achieve Lymphatic Filariasis Elimination
This technical brief discusses WHO's Global Programme to Eliminate Lymphatic Filariasis (GPELF) and Act | West's approach that is used to support countries to achieve LF elimination.
Act | West Countries' FY24 Work Plans
FY24 Work Plans for each of Act | West's 11 countries.
Act | West FY 23 Semi-Annual Report: October 2022 - March 2023
This report outlines the key achievements and challenges in the first six months of the fifth year of program implementation, spanning the period October 2022 - March 2023.
Act | West FY 22 Semi-Annual Report: April 2022 - September 2022
This report outlines the key achievements and challenges in the last six months of the fourth year of program implementation, spanning the period April 1, 2022 - September 31, 2022.
Act | West Countries' FY23 Work Plans
FY23 Work Plans for each of Act | West's 11 countries.
Microplanning manual to guide implementation of preventive chemotherapy to control and eliminate neglected tropical diseases
WHO manual on implementing preventative chemotherapy against neglected tropical diseases provides generic tools for those involved in planning preventative chemotherapy administration. The publication was released in September 2022.
WHO standard operating procedures for supply chain management of health products for neglected tropical diseases amenable to preventive chemotherapy
New WHO standard operating procedures--released on July 25, 2022--describes the standard operating procedures for health products for NTDs amenable to preventive chemotherapy and the medicines donated to treat them.
Act | West FY 22 Semi Annual Report: October 2021 - March 2022
This report outlines the key achievements and challenges in the first six months of the fourth year of program implementation, spanning the period October 1, 2021–March 31, 2022.